Clinical trial · Interventional
DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer
NCT00400426CI-TRIAL-00010780completedPhase 2ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Palliative radiotherapy for head and neck cancer is widely used but the effect and side effects are largely unknown. We will study the effect of short hypofractionated palliative radiotherapy (20 Gy in 4 fractions) on symptom intensity and -frequency as weel as side effects
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Neoplasms | Head and Neck Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Neoplasms, Second Primary | Neoplasm | ONTOLOGY_EXACT | 0.85 |
| Recurrence | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Radiotherapy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Frequency and intensity of symptoms before and after radiotherapy (EORTC C30 and H&N35 questionnaires and CTC AE 3.0 toxicity scores)
- timeFrame
- 11 mths
Secondary outcomes (3)
- measure
- Survival
- timeFrame
- 11 mths
- measure
- Side effects
- timeFrame
- 2 mths
- measure
- Other treatments
- timeFrame
- 11 mths
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Incurable primary or second primary head and neck cancer * Speaks and reads Danish * Capable of filling out questionnaires for at leas two months after radiotherapy * Age\>=18 years * Expected survival\> 3months
References
Publications (0)
Data not yet available
No reference posted for this study.